These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16716)

  • 1. Beta-2 adrenoceptor blocking activity of penbutolol and propranolol at very low doses.
    Kulkarni RD; DaSilva LM; Chabria NL; Chadha DR
    Clin Pharmacol Ther; 1977 Jun; 21(6):685-90. PubMed ID: 16716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic and kinetic comparison of penbutolol and propranolol in healthy volunteers [proceedings].
    Baird IM; Hill H; Ings RM; Johnson KI; McEwen J
    Br J Clin Pharmacol; 1977 Jun; 4(3):386P. PubMed ID: 20121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-effect and kinetic-dynamic relationships of the beta-adrenoceptor blocking properties of various doses of talinolol in healthy humans.
    de Mey C; Schroeter V; Butzer R; Jahn P; Weisser K; Wetterich U; Terhaag B; Mutschler E; Spahn-Langguth H; Palm D
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):879-8. PubMed ID: 8606523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect on myocardial contractility of a new beta-adrenergic receptor blocking drug, penbutolol.
    Sapru RP; Sharma PL
    Br J Clin Pharmacol; 1978 Dec; 6(6):515-20. PubMed ID: 728320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic sympathomimetic activity of penbutolol.
    Nyberg G; Wilhelmsson C; Vedin A
    Eur J Clin Pharmacol; 1979; 16(6):381-6. PubMed ID: 43255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 16. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative beta adrenoreceptor blocking effect of propranolol and penbutalol. Preliminary observations.
    Khanna PK; Balasubramanian V; Chatterji JC; Hoon RS
    J Assoc Physicians India; 1978 Mar; 26(3):143-6. PubMed ID: 32165
    [No Abstract]   [Full Text] [Related]  

  • 18. [Penbutolol: beta-adrenergic blocking effect on isolated guinea pig atria].
    Dagrosa EE; Rothlin RP
    Medicina (B Aires); 1979; 39(2):203-7. PubMed ID: 502830
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats.
    Zhang HT; Huang Y; O'Donnell JM
    Psychopharmacology (Berl); 2003 Oct; 170(1):102-7. PubMed ID: 12898120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.